DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Grunberger G, Chang A, Garcia Soria G et al.
Monotherapy with the once-weekly GLP-1 analogue dulaglutide for 12 weeks in patients with Type 2 diabetes: dose-dependent effects on glycaemic control in a randomized, double-blind, placebo-controlled study.
Diabet Med 2012;
29: 1260-1267
Access:
We do not assume any responsibility for the contents of the web pages of other providers.